Question 1

Has Hugo Espinosa received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $640,376 in general payments to Hugo Espinosa across 99 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Hugo Espinosa did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Hugo Espinosa come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	13	$506,716
Mallinckrodt LLC	15	$64,850
Neuronetics, Inc.	5	$62,527
Alkermes, Inc.	5	$4,598
AbbVie(2 entities)	29	$456
Otsuka America Pharmaceutical, Inc.	7	$215
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$167
Lundbeck LLC	8	$157
Briohealth Solutions, Inc.	1	$155
Axsome Therapeutics, Inc.	3	$137
Corium, LLC	3	$137
Neurocrine Biosciences, Inc.	1	$125
Vanda Pharmaceuticals Inc.	2	$55
Johnson & Johnson	2	$54
Takeda Pharmaceuticals U.S.A., Inc.	1	$24

Drug	Claims	Cost to plans & patients
Quetiapine Fumarate	17	$287
Mirtazapine	12	$193
Clonazepam	16	$137
Trazodone Hcl	12	$51
Buspirone Hcl	13	$42
Lorazepam	12	$40
Fluoxetine Hcl	12	$22

Hugo Espinosa

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Most prescribed under Part D

Other psychiatry in The Villages